137 related articles for article (PubMed ID: 23332556)
1. Prevalence of antiphospholipid antibodies in patients with subacute and chronic cutaneous lupus erythematosus.
García-Martín P; García-García C; Fraga J; García-Díez A
Actas Dermosifiliogr; 2013 Apr; 104(3):232-8. PubMed ID: 23332556
[TBL] [Abstract][Full Text] [Related]
2. Extended Antiphospholipid Antibodies Screening in Systemic Lupus Erythematosus Patients.
Dima A; Caraiola S; Jurcut C; Balanescu E; Balanescu P; Ramba D; Badea C; Pompilian V; Ionescu R; Baicus A; Baicus C; Dan GA
Rom J Intern Med; 2015; 53(4):321-8. PubMed ID: 26939208
[TBL] [Abstract][Full Text] [Related]
3. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal study of antinuclear and anticardiolipin antibodies in pregnant women with systemic lupus erythematosus and antiphospholipid syndrome.
Salazar-Páramo M; Jara LJ; Ramos A; Barile L; Machado G; García-De La Torre I
Rheumatol Int; 2002 Aug; 22(4):142-7. PubMed ID: 12172952
[TBL] [Abstract][Full Text] [Related]
6. [Antiphospholipid syndrome and stroke].
Kitagawa Y
Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
[TBL] [Abstract][Full Text] [Related]
7. Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease.
Souza A; da Silva LM; Oliveira FR; Roselino AM; Louzada-Junior P
Lupus; 2009 Mar; 18(3):223-9. PubMed ID: 19213860
[TBL] [Abstract][Full Text] [Related]
8. Pattern of disease expression in SLE patients with antiphospholipid antibodies: data from Indian Systemic Lupus Erythematosus Inception cohort (INSPIRE).
Shobha V; Rajasekhar L; Manuel S; Nayana V; Kavadichanda C; Kounassegarane D; Mathew AJ; Gupta R; Rathi M; Ghosh P; Tripathy SR; Das B; Selvam S; Singh AK; Singh A; Jain A; Aggarwal A
Rheumatol Int; 2024 May; 44(5):819-829. PubMed ID: 38082159
[TBL] [Abstract][Full Text] [Related]
9. IgG anti-beta2-glycoprotein I antibodies in adult patients with systemic lupus erythematosus: prevalence and diagnostic value for the antiphospholipid syndrome.
Tubach F; Hayem G; Marchand JL; Weber M; Palazzo E; de Bandt M; Roux S; Kahn MF; Meyer O
J Rheumatol; 2000 Jun; 27(6):1437-43. PubMed ID: 10852267
[TBL] [Abstract][Full Text] [Related]
10. Epidemiological characteristics of patients with cutaneous lupus erythematosus.
Avilés Izquierdo JA; Cano Martínez N; Lázaro Ochaita P
Actas Dermosifiliogr; 2014; 105(1):69-73. PubMed ID: 24268922
[TBL] [Abstract][Full Text] [Related]
11. Antiphospholipid antibody tests: spreading the net.
Bertolaccini ML; Gomez S; Pareja JF; Theodoridou A; Sanna G; Hughes GR; Khamashta MA
Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
[TBL] [Abstract][Full Text] [Related]
12. The prevalence of antiphospholipid antibody syndrome among systemic lupus erythematosus patients.
McMahon MA; Keogan M; O'Connell P; Kearns G
Ir Med J; 2006; 99(10):296-8. PubMed ID: 17274170
[TBL] [Abstract][Full Text] [Related]
13. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
[TBL] [Abstract][Full Text] [Related]
14. [Pregnancy and antiphospholipid antibodies in systemic lupus erithematosus patients: an outcome evaluation].
Cordeiro A; Lermann R; Ambrósio P; Nogueira I; Serrano F
Acta Reumatol Port; 2009; 34(3):486-91. PubMed ID: 19820672
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden.
Grönhagen CM; Fored CM; Granath F; Nyberg F
Br J Dermatol; 2011 Jun; 164(6):1335-41. PubMed ID: 21574972
[TBL] [Abstract][Full Text] [Related]
17. The significance of antiphospholipid antibodies in liver recipients.
Furmańczyk-Zawiska A; Tronina O; Baczkowska T; Chmura A; Durlik M
Transplant Proc; 2013 Jun; 45(5):1983-9. PubMed ID: 23769090
[TBL] [Abstract][Full Text] [Related]
18. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
Fanopoulos D; Teodorescu MR; Varga J; Teodorescu M
J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168
[TBL] [Abstract][Full Text] [Related]
19. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus.
Danowski A; Kickler TS; Petri M
J Rheumatol; 2006 Sep; 33(9):1775-9. PubMed ID: 16960938
[TBL] [Abstract][Full Text] [Related]
20. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
